Mitral Valve Surgery in the Presence of Pulmonary Hypertension

Creative Commons License

PAŞAOĞLU İ., Ersoy ü., Böke E., Bozer Y., DEMİRCİN M., DOĞAN R., ...More

Japanese Heart Journal, vol.33, no.2, pp.179-184, 1992 (Scopus) identifier identifier

  • Publication Type: Article / Article
  • Volume: 33 Issue: 2
  • Publication Date: 1992
  • Doi Number: 10.1536/ihj.33.179
  • Journal Name: Japanese Heart Journal
  • Journal Indexes: Scopus
  • Page Numbers: pp.179-184
  • Keywords: Mitral valve, Mitral valve replacement, Open mitral commissurotomy, Pulmonary hypertension
  • Hacettepe University Affiliated: Yes


Mitral valve surgery was performed in 59 patients with severe pulmonary hypertension (average systolic pulmonary artery pressure 77.1 ± 18.6 mmHg; range 50-115 mmHg) between 1983 and 1990. Thirty-eight patients had been subjected to mitral valve replacement, 16 patients both mitral and aortic valve replacement, and 5 patients had open mitral commissurotomy, with an operative (30 day) mortality of 5.0%. These 3 deaths happened during the early postoperative period. Survivors were followed up for a period ranging from 6 months to 7 years with a mean of 36 months. Four late deaths (7.1%) occurred in patients with valve replacement. Actuarial survival was 93 ± 3% at 5 years, and 90.7 ± 4.4% at 7 years. Right ventricular catheterization was performed on 14 patients a mean of 38 months following operation. Systolic pulmonary artery pressure had decreased from a mean of 77.1 ± 18.6 to 39.7 ± 14.0 mmHg (p<0.001) and 90% of the survivors were in New York Heart Association Glass 1 or II compared to 23.7% preoperatively. The clinical and hemodynamic findings in this series suggest that severe pulmonary hypertension is not a contraindication, and pulmonary hypertension decreases significantly after mitral valve surgery. © 1992, International Heart Journal Association. All rights reserved.